Litcius/Paper detail

Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells

Bakiye Göker Bağca, Neslihan Pınar Özateş, Aycan Aşık, Hasan Onur Çağlar, Cumhur Gündüz, Çığır Biray Avcı

2020Biochemical and Biophysical Research Communications14 citationsDOI

Topics & Concepts

TemozolomidePI3K/AKT/mTOR pathwayViability assayApoptosisProtein kinase BCell cycleFlow cytometryCancer researchCombination therapyPharmacologyChemistryBiologyGlioblastomaMolecular biologyBiochemistryGlioma Diagnosis and TreatmentCancer Mechanisms and TherapyHistone Deacetylase Inhibitors Research
Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells | Litcius